See also this year's filing and all EDGAR filings for this company.
PDF Report 0001080709_2022_Arena_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001080709, Arena Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 569,465,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 19,125,000 |
| 3 | remainder_Assets | 196,115,000 |
| 4 | LiabilitiesCurrent | 66,316,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 182,403,733 |
| 9 | ResearchAndDevelopmentExpense | 713,235,096 |
| 10 | remainder_Expenses | 37,988,755 |
| 11 | remainder_Revenues | 145,169 |
| 12 | remainder_NetIncome | 9,021,459 |
| 13 | remainder_ComprehensiveNetIncome | -930,744 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 784,705,000 |
| 1 | Liabilities | 66,316,000 |
| 2 | Expenses | 933,627,584 |
| 3 | Revenues | 145,169 |
| 4 | StockholdersEquity | 718,389,000 |
| 5 | NetIncome | -924,460,956 |
| 6 | ComprehensiveNetIncome | -924,926,328 |
| 7 | BaseVar | 897,372,978 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.51 |
| 9 | EconomicCapitalRatio | 2.68 |
Edgar->Model Mapping
Feature Distribution
Change over Time
